---
title: "Safinamide - Parkinson'S Disease"
sidebar: mydoc_sidebar
permalink: db06654-mesh-d010300-1.html
toc: false 
---


Path ID: `DB06654_MESH_D010300_1`
{% include image.html url="images/db06654-mesh-d010300-1.png" file="db06654-mesh-d010300-1.png" alt="db06654-mesh-d010300-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C092797 | Safinamide | Drug |
| UniProt:P27338 | Amine oxidase [flavin-containing] B | Protein |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D010300 | Parkinson's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Safinamide | DECREASES ACTIVITY OF | Amine Oxidase [Flavin-Containing] B |
| Amine Oxidase [Flavin-Containing] B | DECREASES ABUNDANCE OF | Dopamine |
| Dopamine | PARTICIPATES IN | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | DISRUPTED BY | Parkinson'S Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06654](https://go.drugbank.com/drugs/DB06654)
